Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency

被引：4

作者：

Pashangzadeh, S. ^{[1
]}

Delavari, S. ^{[1
,2
]}

Shad, T. Moeini ^{[1
]}

Salami, F. ^{[1
,2
]}

Rasouli, S. E. ^{[1
,3
]}

Yazdani, R. ^{[1
]}

Mahdaviani, S. A. ^{[4
]}

Nabavi, M. ^{[5
]}

Aleyasin, S. ^{[6
]}

Ahanchian, H. ^{[7
]}

Jabbari-Azad, F. ^{[7
]}

Chavoshzadeh, Z. ^{[8
]}

Nazari, F. ^{[1
]}

Momen, T. ^{[9
]}

Sherkat, R. ^{[10
]}

Abolnezhadian, F. ^{[11
]}

Esmaeilzadeh, H. ^{[6
]}

Fallahpour, M. ^{[6
]}

Arshi, S. ^{[5
]}

Bemanian, M. H. ^{[5
]}

Shokri, S. ^{[5
]}

Ebrahimi, S. S. ^{[12
]}

Abolmolouki, M. ^{[1
]}

Farid, A. S. ^{[1
]}

Rezaei, A. ^{[1
]}

Esmaeili, M. ^{[1
,2
]}

Kalantari, A. ^{[13
]}

Sadeghi-Shabestari, M. ^{[14
]}

Shirkani, A. ^{[15
]}

Behniafard, N. ^{[16
]}

Khalili, A. ^{[17
]}

Eslamian, M. H. ^{[18
]}

Cheraghi, T. ^{[19
]}

Shafie, A. ^{[20
]}

Tavakol, M. ^{[3
]}

Khoshkhui, M. ^{[7
]}

Iranparast, S. ^{[21
]}

Shamshiri, M. ^{[21
]}

Shahri, M. A. ^{[1
]}

Khazaei, R. ^{[11
]}

Asadi, M. ^{[1
]}

Babaha, F. ^{[1
]}

Aghamohammadi, A. ^{[1
]}

Rezaei, N. ^{[1
,2
]}

Abolhassani, H. ^{[1
,22
]}

机构：

[1] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Pediat Ctr Excellence, Childrens Med Ctr, Tehran, Iran

[2] Universal Sci Educ & Res Network USERN, Primary Immunodeficiency Dis Network PIDNet, Tehran, Iran

[3] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran

[4] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Pediat Resp Dis Res Ctr, Tehran, Iran

[5] Iran Univ Med Sci, Rasool E Akram Hosp, Dept Allergy & Clin Immunol, Tehran, Iran

[6] Shiraz Univ Med Sci, Allergy Res Ctr, Shiraz, Iran

[7] Mashhad Univ Med Sci, Allergy Res Ctr, Mashhad, Iran

[8] Shahid Beheshti Univ Med Sci, Mofid Childrens Hosp, Pediat Infect Res Ctr, Tehran, Iran

[9] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommunicable Dis, Dept Allergy & Clin Immunol, Child Growth & Dev Res Ctr, Esfahan, Iran

[10] Isfahan Univ Med Sci, Immunodeficiency Dis Res Ctr, Esfahan, Iran

[11] Ahvaz Jundishapur Univ Med Sci, Abuzar Childrens Hosp, Dept Pediat, Ahvaz, Iran

[12] Kerman Univ Med Sci, Dept Immunol & Allergy, Kerman, Iran

[13] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Immunol & Allergy, Tehran, Iran

[14] Tabriz Univ Med Sci, Dept Immunol & Allergy, Tabriz, Iran

[15] Bushehr Univ Med Sci, Sch Med, Allergy & Clin Immunol Dept, Bushehr, Iran

[16] Shahid Sadoughi Univ Med Sci, Children Growth Disorder Res Ctr, Yazd, Iran

[17] Shahid Sadoughi Univ Med Sci, Dept Pediat, Yazd, Iran

[18] Hamedan Univ Med Sci, Dept Pediat, Hamadan, Iran

[19] Guilan Univ Med Sci, 17 Shahrivar Childrens Hosp, Dept Pediat, Rasht, Iran

[20] Univ Tehran Med Sci, Bahrami Hosp, Dept Immunol, Tehran, Iran

[21] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Immunol, Ahvaz, Iran

[22] Karolinska Inst, Dept Med Biochem & Biophys, Div Immunol, Stockholm, Sweden

来源：

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2024年 / 34卷 / 04期

关键词：

Primary immunodeficiency; Inborn errors of immunity; Common variable immunodeficiency.Autoimmunity; immunodeficiency.Autoimmunity; Malignancy; Immune dysregulation; REGULATORY T-CELLS; IGA DEFICIENCY; AUTOIMMUNITY; DISORDERS; SUBSETS; COHORT; LYMPHOCYTES; PHENOTYPE; CHILDREN; CRITERIA;

D O I：

10.18176/jiaci.0902

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Background: Common variable immunodeficiency (CVID) is considered the most symptomatic type of inborn errors of immunity in humans. Along with infectious complications, which have numerous consequences, noninfectious complications are a major challenge among CVID patients. Methods: All CVID patients registered in the national database were included in this retrospective cohort study. Patients were divided into 2 groups based on the presence of B-cell lymphopenia. Demographic characteristics, laboratory findings, noninfectious organ involvement, autoimmunity, and lymphoproliferative diseases were evaluated. Results: Among 387 enrolled patients, 66.4% were diagnosed with noninfectious complications and 33.6% with isolated infectious presentations. Enteropathy, autoimmunity, and lymphoproliferative disorders were reported in 35.1%, 24.3%, and 21.4% of patients, respectively. Some complications, including autoimmunity and hepatosplenomegaly, were reported to be significantly more frequent among patients with B-cell lymphopenia. As for organ involvement, the dermatologic, endocrine, and musculoskeletal systems were predominantly affected in CVID patients with B-cell lymphopenia. Among autoimmune manifestations, the frequency of rheumatologic, hematologic, and gastrointestinal autoimmunity was reported to be higher than that of other types of autoimmunity not associated with B cell-lymphopenia. Furthermore, hematological cancers, particularly lymphoma, were the most common type of malignancy. The mortality rate was 24.5%, and respiratory failure and malignancies were the most common causes of death, with no significant differences between the 2 groups. Conclusion: Considering that some of the noninfectious complications might be associated with B-cell lymphopenia, regular patient monitoring and follow-up with proper medication (in addition to immunoglobulin replacement therapy) are highly recommended to prevent sequelae and increase patient quality of life.

引用

页码：233 / 245

页数：13

共 50 条

[31] Changes in B cell immunophenotype in common variable immunodeficiency: cause or effect - is bronchiectasis indicative of undiagnosed immunodeficiency?
Bright, P.
Grigoriadou, S.
Kamperidis, P.
Buckland, M.
Hickey, A.
Longhurst, H. J.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 171 (02) : 195 - 200
[32] Common Variable Immunodeficiency
Remiker, Allison
Bolling, Kristina
Verbsky, James
MEDICAL CLINICS OF NORTH AMERICA, 2024, 108 (01) : 107 - 121
[33] Common Variable Immunodeficiency
Biman Saikia
Sudhir Gupta
The Indian Journal of Pediatrics, 2016, 83 : 338 - 344
[34] Common variable immunodeficiency
Tam, Jonathan S.
Routes, John M.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (04) : 260 - 265
[35] Common Variable Immunodeficiency and Liver Involvement
Junmin Song
Ana Lleo
Guo Xiang Yang
Weici Zhang
Christopher L. Bowlus
M. Eric Gershwin
Patrick S. C. Leung
Clinical Reviews in Allergy & Immunology, 2018, 55 : 340 - 351
[36] Granulomatous disease in common variable immunodeficiency
Ardeniz, Oemuer
Cunningham-Rundles, Charlotte
CLINICAL IMMUNOLOGY, 2009, 133 (02) : 198 - 207
[37] Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency
Berbers, Roos-Marijn
van der Wal, M. Marlot
van Montfrans, Joris M.
Ellerbroek, Pauline M.
Dalm, Virgil A. S. H.
van Hagen, P. Martin
Leavis, Helen L.
van Wijk, Femke
JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (07) : 1621 - 1632
[38] Lymphoproliferative disease and cancer among patients with common variable immunodeficiency
Gangemi, S.
Allegra, A.
Musolino, C.
LEUKEMIA RESEARCH, 2015, 39 (04) : 389 - 396
[39] Monitoring patients with uncomplicated common variable immunodeficiency: a systematic review
Lee, Erika Yue
Betschel, Stephen
Grunebaum, Eyal
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01)
[40] Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders
Yazdani, R.
Abolhassani, H.
Asgardoon, M.
Shaghaghi, M.
Modaresi, M.
Azizi, G.
Aghamohammadi, A.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2017, 27 (04) : 213 - 224

← 1 2 3 4 5 →